Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2000

View Archived Issues

Promising initial results for Synvisc in osteoarthritis of the hip

Chiron reports new durable response data for Proleukin

NR2B NMDA receptor antagonist shows antiparkinsonian activity

MacroChem to begin phase III home trial of Topiglan

Different rifalazil regimens examined against M. tuberculosis in mice

Bristol-Myers Squibb and 3-D form alliance

Potential new antipsychotic agent presented by Servier at CINP Congress

Nootropic profile and mechanisms of action of (-)-clausenamide undergo investigation

Draxis initiates phase I study for new imaging agent for heart attacks

Dietary restriction protects against neurodegeneration by enhancing neurotrophic factor signaling

La Jolla Pharmaceutical chooses candidate for blood clotting disorder

Indian herbal preparation: evidence of efficacy in subjects with age-related cognitive decline

Cambridge NeuroScience licenses neuregulin-2 from Harvard

Imidazolidinone antipsychotic agent from Servier interacts with NMDA receptors at the glycine B site

KS Biomedix acquires antigen/antibody for ulcerative colitis

Arthritis Advisory Committee recommends new approval for Remicade

CART technology identifies selective 5-HT2A inverse agonist and putative atypical antipsychotic

Reminyl completes E.U. mutual recognition procedure

Humanized MAbs that neutralize interferon gamma described by PDL

Metabolic disorder collaboration between BMS and Karo Bio extended

Neuron-associated proteins discovered by Incyte, covered by recent patent

Centaur's new antiinflammatory agents reportedly act by inhibiting COX-2 induction

Noncytotoxic immunosuppressive agent discovered by Sankyo in Streptomyces culture

New compounds interacting with NPY receptors useful for eating disorders, etc.

Tetrapeptide inhibitors of caspase 3 discovered by Merck Frosst

Production and use of new AChR modulators reported by NeuroSearch

New series of psoralen-based photochemotherapeutics claimed by Buckman Laboratories

Dual alpha2-adrenoceptor blockers/monoamine reuptake inhibitors designed at ADIR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...